Biobanking Market Forecasts 2016-2026

May 17, 2016, 09:00 ET from Visiongain Ltd

LONDON, May 17, 2016 /PRNewswire/ --

- Discover Prospects for Medical Research and Therapeutic Uses, Including Human Tissues, Fluids and Stem Cells

- Biobanks - How to Discover Trends, R&D and Sales Forecasts From 2016, Helping Your Influence

Are you interested in the future of medical biobanking? If so, you can now gain technological and commercial predictions from 2016. That way you stay ahead for data, benefiting your authority. There explore trends in research and development, results, opportunities and revenue forecasts.

That new study by visiongain shows you what is possible for biobanking and associated technology for human healthcare. Avoid missing out. Instead find sales potentials for that biomedical industry and market, discovering expected trends, progress and financial gains.

Biobank services and technology exert great influence on drug discovery and development. That importance increases from 2016. See what the future holds.

Potential of those biorepository technologies and storage facilities
In medical research those biostorage systems form an important resource. They support fields including genomics and personalised medicine, letting companies store and use samples.

Our report's purpose is showing you the commercial potential in storing human biological samples for use in research and therapies, including conserving stem cells.

Please read on to explore those technologies and services for human medicine, finding what influences that market and seeing predicted revenue.

Forecasts and other information showing lucrative possibilities for biorepositories
Our study gives sales predictions to 2026 at overall world, submarket and national level. You also get sample unit predictions. For biosample and biospecimen storage, especially for pharmaceutical R&D, you investigate where applications, needs, demand and money lie.

To see a report overview please email Sara Peerun on sara.peerun@visiongainglobal.com

Why struggle to find information or miss data you need on medical biopreservation? Besides revenue forecasting, our new analysis shows you results, growth rates and market shares.

There you explore those technologies for medical R&D - especially applications suiting drug companies. Our new report gives you 72 tables, 74 charts and three interviews with authorities in that field. Discover, from 2016, the potential of biobanks.

Forecasting of that world market and its segments - you find commercial prospects
See in our report overall world revenue to 2026, with discussions, for storing human cell, tissue and fluid samples.

That way you can help your research, analyses and decisions on storage of human biological samples (HBS). As someone with authority, benefit your reputation for technological and commercial insight.

In particular find individual revenue predictions to 2026 for nine submarkets at world level:
• Biobanking for research
• Biobanking for therapeutic uses.

There you find biobanking revenue forecasting to 2026 by research application:
• Human tissues - also with sub-forecasts for public sector and commercial uses
• Stem cells
• Other biological sample banking applications - inc. DNA and body fluids.

And our analysis predicts stem cell banking revenues to 2026 for therapeutic uses:
• Umbilical cord stem cell banking
• Adult stem cell banking.

You also get forecasts to 2026 for the number of samples banked for research and therapeutic applications.

In our study you assess outlooks for sales expansion, hearing where you could gain. That work explores competition and demand, showing technological and commercial possibilities.

So hear what is happening. You also investigate geographical revenue potentials.

Biostorage needs in leading national markets - what outlooks for demand, sales and capacity?
In developed and developing countries, opportunities for companies providing biorepository facilities, products, services, consumables and technology will expand from 2016.

Our analyses show you individual revenue forecasts to 2026 for 12 leading national biobanking markets:
• The US
Japan
Germany, France, the UK, Italy, Spain and the Netherlands
Brazil, Russia, India and China.

There discover countries with highest sales, demand and potential expansion of usage and revenues. That way you investigate progress, needs, opportunities and competitors. And you see the gains possible, finding how you could expand your business.

Also what events, challenges and advances in technology affect biorepositories?

Forces influencing suppliers and users of those biomedical resources and libraries
Our new study explores issues, events and contributions affecting that industry and market from 2016, including these influences:
• Guidelines, research and medical ethics, standards (e.g. GLP), legislation, regulations and governmental funding for that biopreservation, inc. HIPAA amendments
• Systems for cryopreservation, biobank networks and biobanking infrastructure
• Facilities, freezers, operations software, consumables and services
• Biobanking in research, drug discovery and development, inc. biomarkers and personalised medicine
• Uses in therapeutics, clinical trials and genome-wide association studies (GWAS).

And you explore these forces, among others:
• Numbers and geographical distribution of biobanks
• Umbilical cord blood banking and induced pluripotent stem cells (iPSCs)
• RFID, tagging technology and laboratory information management systems (LIMS)
• Technologies and services aiding genetic epidemiology studies and understanding of disease pathways
• Automated liquid handling systems, and automation in DNA isolation
• Biobanking services - sample storage, tracking, management and transport of human biological samples.

That way you find what stimulates and restrains organisations performing and helping that biosample preservation, affecting their results and those of biobank clients.

Technologies and applications - top organisations and 2020 market value
What future sales results are possible? Our study predicts that the world biobanking market will generate $27.5bn in 2020. Rising demand for biobanked samples for use by pharmaceutical companies in preclinical research most stimulates biobanking revenues.

Our analysis shows activities of biobanks, including these organisations:
• Stemgent
• Biopta
• BioServe
• Coriell Institute for Medical Research
• Cord Blood America
• Cryo-Cell International.

And other companies, including these:
• China Cord Blood Corp
• LifebankUSA
• ViaCord
• Cord Blood Registry
• Biogenea Pharmaceuticals
• StemLife
• Caladrius Biosciences.

That way you assess competitors and developments. Our analysis includes interviews with Fidelis Research, Bulgaria, 3C-R, France, and the UK ME/CFS Biobank Project. So avoid missing out in knowledge. See what other authorities say and do, helping your work.

Five ways Biobanking Market Forecasts 2016-2026 helps your work
In these five main ways, our new investigation helps you get recognition for insight, saving time and benefiting your authority:
• Revenues for biobanking, to 2026, at world level and for 9 submarkets - explore prospects for design, production, sales, marketing, demand and spending
• Forecasts, to 2026, for 12 countries in the Americas, Europe and Asia - assess developed and developing national markets for demand and predicted revenues
• Prospects for established organisations, rising companies and new entrants - examine service and product portfolios, results, strategies and outlooks for success
• Analysis of what stimulates and restrains that industry's participants - investigate challenges, strengths and competition affecting organisations' results
• Interviews with organisations - discover what authorities in that field say and do, helping you stay ahead in knowledge to help your work.

That report, by visiongain's UK-based analysts, gives knowledge to benefit your research, analyses, plans, decisions and proposals. You get data leading companies depend on.

Information there found nowhere else, helping your searches, analyses and planning
An off-the-shelf report cannot answer every question, though our work explains that industry's structures, outlooks and potentials.

Our analyses give independent data. There you get competitive intelligence found only in that study, finding where progress, money and opportunities lie. See what the future holds.

With that research and analysis you are less likely to fall behind in knowledge or miss opportunity. There see how you could save time and effort. And benefit your plans, decisions and presentations, helping you gain advantages and recognition.

Trying our study now lets you discover biobanking opportunities and predictions
Stay ahead in data. Our new investigation is for everyone analysing medical biotechnology and pharmaceutical R&D. For storing biological samples you see trends, opportunities and revenue predictions. So avoid missing out - please get our new report here now.

To see a report overview please email Sara Peerun on sara.peerun@visiongainglobal.com

To request an exec summary of this report please email Sara Peerun at sara.peerun@visiongainglobal.com or call Tel: +44 (0) 20 7336 6100

Or click on https://www.visiongain.com/Report/1635/Biobanking-Market-Forecasts-2016-2026

Company mentioned  

3C-R    

100,000 Genomes Project

Abbott Laboratories

Accelrys    

AdeptBio    

Adnexus Therapeutics

Advanced Innovative Medicine

AIS    

AKH Biobank

AllCells    

Allied Minds

AlloSource

AMAG Pharmaceuticals

American Association of Tissue Banks

American CryoStem

American Type Culture Collection (ATCC)

Amgen    

Analytical Biological Services

ARUP Laboratories

ASPREE Healthy Ageing Biobank

AssureImmune

Asterand Biosciences

AstraZeneca

Aurora Biomed

Australian Biospecimen Network (ABN)

Autoscribe Informatics

AuxoCell Laboratories

AXM Shenyang

Bangalore Brain Bank

Barts Gynae Tissue Bank

Bavarian Red Cross (BRK)

Bayer    

BBMRI    

Beckman Coulter

Benelux    

BINDER    

Biobank Ireland Trust

BioCision    

Biocordcell Argentina

BioEden    

BioFortis    

Biogen Idec

Biogenea    

Biogenea Pharmaceuticals

BioLife Solutions

Biomatrica

Biomedical Research Council (BMRC)

Biopta    

BioreclamationIVT

BioRep    

BioRepository Resources

Bioserve Biotechnologies

BioServe Biotechnologies India

BioStorage Technologies

Biovault Technical

BIOVIA    

Bluechiip Ltd.

BrainNet Europe

Bristol-Myers Squibb

British Birth Cohort

Brooks    

Brooks Life Science Systems

Caladrius Biosciences

Cambridge Biomedical Research Centre

Cambridge Biosciences

Canadian Partnership for Tomorrow

Cancer Genetics Inc

Cancer Genetics India

Cancer Human Biobank (caHUB)

CCLG Tissue Bank

Celgene Cellular Therapeutics

Cells4Life

Celltex Therapeutics

Cellular Dynamics

Center for iPS Cell Research and Applications (CiRA)

Centro Nazionale per le Risorse Biologiche (CNRB)

Cesca Therapeutics

Chernobyl Tissue Bank

China Cord Blood Corp.

China Kadoorie Biobank

China Stem Cells

CIRM (California Institute of Regenerative Medicine)

CLB/Amsterdam Medical Center

Clinical Proteomic Tumor Analysis Consortium (CPTAC)

CMD Biobank

CONCOR    

CorCell    

Cord Blood Registry (CBR)

CordBlood America

CordLife    

CordVida    

CORE Informatics

Coriell Institute for Medical Research

Council of Europe (CoE)

Covance    

Croydon NHS Trust

Cryo Bio System

Cryo Save

Cryo-Cell International

Cryogene Lab

CryoLogic

Cryopraxis

CryoXtract Instruments

Cureline    

Custom Biogenic Systems

Cybrdi    

Daifuku    

Danubian Biobank Consortium

deCODE Genetics

Deloitte    

Scottish Government

Eli Lilly    

EMA    

Eppendorf

Esco    

Estonian Genome Center

European Association for Predictive, Preventative & Personalised Medicine (EPMA)

European Bank for induced pluripotent stem cells (EBiSC)

European Commission (EC)

European Federation of Pharmaceutical Industries and Associations (EFPIA)

European Health Risk Monitoring (EHRM)

European Research Infrastructure Consortium (ERIC)

European Union Group on Ethics (EGE)

FDA    

Fisher BioServices

FluidX    

Fox Chase Cancer Centre

Future Health Biobank

GC Biotech

GE Healthcare

GE Healthcare SeqWright Genomic Services

Genentech

GenVault    

Germany Cryo

Gilson    

GlaxoSmithKline

Golden Meditech Holdings

H. Lee Moffitt Cancer Center and Research Institute

Haier Biomedical

Hamilton    

Hamilton Robotics

Hamilton Storage Technologies

Harvard Stem Cell Institute

Hitachi Chemical

Hospital Necker Paris

Hubris (HUNT Biobank Resource Information System)

Hudson Robotics

Human Genome Project

Human Longevity

Human Science Research Resource Bank (HSRRB)

Human Tissue Bank

Hungarian Biobank

HUNT Norway

Huntington Disease Biobank

ILSBio    

Imperial Tissue Bank

Inbiomed    

Indian Institute of Technology

Indivumed

Infectious Disease Biobank

INSERM    

Instituto de Salud Carlos III (ISCIII)

IntegenX    

International Agency for Research on Cancer (IARC)

International Organization for Standardization

International Society for Biological and Environmental Repositories (ISBER)

International Stem Cell Corporation

Japan Health Sciences Foundation

Kaiser Permanente

King's College London Tissue Bank

KORAgen    

Kyoto University

Labtech    

Labvantage Solutions

Labware    

LBD Life Sciences

Leiden Longevity

Leiden University Medical Center

LifeBank USA

LifeCell    

LifeGene    

LifeLines Biobank

Malmo Microbiology Biobank

MatriCal Biosciences

Medical Research Council

Merck & Co.    

Merck-Serono

Micronic    

Minister of State for Public Health

Ministry of Health and Welfare

Mitochondrial Disease Biobank

MSD    

Nanjing Xinjiekou Department Store Co.

Narayana Hrudayalaya Tissue Bank and Stem Cell Research Center

National Cancer Institute (NCI)

National Health and Family Planning Commission (NHFPC)

National Institute of Standards and Technology (NIST)

National Institutes of Biomedical Innovation, Health and Nutrition (NIBHN)

National Institutes of General Medical Sciences  (NIGMS)

National Institutes of Health (NIH)

NeoStem    

NESDA    

Netherlands Twin Registry

NHS Blood and Transplant Cord Blood Bank

NIGMS Human Genetic Cell Repository

Northwest Regional Development Agency

Novare Biologistics

Novartis    

Ocimum Biosolutions

Office of Biorepositories and Biospecimen Research (OBBR)

OnCore UK

Organisation for Economic Co-operation and Development (OECD)

OriGene    

P3G Consortium (Public Population Projects in Genomics)

Pacific BioStorage

PALGA    

Panasonic Biomedical

Parelsnoer

PerkinElmer

Pfizer    

Pharmacells

Pharmagene

Pop-Gen National Cohort

Precious Cells

Precision Bioservices

PrecisionMed

PREVEND    

Progenicyte

Progenitor Cell Therapy (PCT)

ProMedDx

Promega    

ProteoGenex

Provia Labs

Qiagen    

RAND    

ReproCELL Group

Riken BRC Cell Bank

Roche    

Rotterdam Study

RTS Life Sciences

Russian Society of Personalised Medicine (RSPM)

Saneron CCEL Therapeutics

Sanofi    

Sapien Biosciences

Sartorius Stedim Biotech

Sceil    

Seattle Genetics

Sechenov First Moscow Medical University (SFMMU)

S-Evans Biosciences (SEB)

Singapore Biobank (SBB)

Singapore Cord Blood Bank

Singapore Tissue Network (STN)

Smart Cells

Spanish Ministry of Science and Innovation (MICINN)

Spanish National Biobank Network

Stanford Tissue Bank

Stanford University

StarLIMS    

Steelgate    

Stellacure

Stem Cells for Safer Medicine

Stemcyte    

Stemgent    

StemLife    

StemSave    

Swedish Institute for Infectious Disease Control Biobank

System Biosciences

Taiyo Nippon Sanso

TAP Biosystems

Tata Memorial Hospital Tissue Bank

TCG Life Sciences Tissue Bank

TCGA (The Cancer Genome Atlas Project)

Tecan    

The Cambridge Brain Bank

The Centre for Integrated Genomic Medical Research

The Guangzhou Biobank

The National Cancer Tissue Bank

Thermo Genesis

Thermo Scientific

Tissue Solutions

Titan Pharmaceuticals

Totipotent

TRT (Tissue Regeneration Therapeutics)

TTP Labtech

UCL Biobank

UK Biobank

UK Blood Service Collection

UK ME-CFS Biobank

UK Multiple Sclerosis Tissue Bank

UK Parkinson's Disease Tissue Bank

UK Stem Cell Bank

UK Stem Cell Strategic Forum

University of South Florida

University of Tüebingen

US Biomax

US Department of Transportation's (DOT's)

V.A. Almazov Federal Center for Heart, Blood and Endocrinology

ViaCell    

ViaCord    

VidaPlus    

Virgin Health Bank

Wellcome Trust

Wellcome Trust Case-Control Consortium (WTCCC)

Wheaton    

Wisconsin International Stem Cell (WISC) Bank

World Health Organization (WHO)

To see a report overview please email Sara Peerun on sara.peerun@visiongainglobal.com


SOURCE Visiongain Ltd